To collect the safety and efficacy data in patients with metastatic colorectalcancer after giving regorafenib in Indianpatients.
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2585041
下载链接
链接失效反馈官方服务：
资源简介：
Primary outcome(s): 1 AEs
2 changes in ECOG PS from baseline
3 laboratory changes
4 changes in vital signsTimepoint: From the start of regorafenib treatment up to 30 days after the last dose of
regorafenib.
创建时间：
2018-07-15
